Funded Tech Companies
ViaCyte
ViaCyte, based in San Diego, received equity investments from Invus, Adage Capital Management and TPG Capital.
Company Overview
Company Name
ViaCyte
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
3550 General Atomics Ct.
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Company Background Information
Overview
ViaCyte is a preclinical therapeutic company focused on diabetes. Our therapy is based on pancreatic beta cell progenitors (Pro-Islet) derived from human pluripotent stem cells. These cells are implanted using a durable and retrievable encapsulation device.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/11/2021
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Yang
Chief Financial Officer
Brittany Bradrick
Chief Medical Officer
Howard Foyt
Chief Scientific Officer
Kevin D'Amour
Chief Technical Officer
Steve White
Vice President
Manasi Jaiman
VP - Finance
Anne Sandan
VP - General Counsel
Liz Bui
VP - Regulatory Affairs
Steve Kradjian
Company Investors
- Invus
- Adage Capital Management
- TPG Capital
- Bain Capital Life Sciences (Adam Koppel)
- ARTIS Ventures
- Asymmetry Capital Management
- Sanderling Ventures
- RA Capital
- TPG Growth (Heath Lukatch)
- W.L. Gore & Associates
- Asset Management Ventures
- JDRF T1D Fund
- Johnson & Johnson Development Corporation
- Sanderling Ventures (Fred Middleton)
- Pacific Horizon Ventures
- BDC Venture Capital
- Johnson & Johnson Development Corporation (Asish Xavier)
- Asset Management Ventures (Franklin Johnson)
- Pacific Horizon Ventures (Donald Elmer)
Browse more funded tech companies:
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs